| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |